Statistics for medmix AG (id:13092 MEDX)

Valuation metrics

Market cap

385.86M

Enterprise value

618.76M

Trailing P/E (ttm)

1.44K

Forward P/E

11.72

PEG ratio

Price/Sales (ttm)

0.80

Price/Book (mrq)

0.84

Enterprise Value/Revenue

1.29

Enterprise Value/EBITDA

9.74

Overview

Shares outstanding

40.79M

Float

23.99M

Shares short

% Held by insiders

0.41%

% Held by institutions

0.25%

Average volume (10 days)

45.25K

Average volume (90 days)

Price summary

52-Week low

8.63

52-Week high

19.24

52-Week change

-115.74%

Beta

0.76

50-Day moving average

9.87

200-Day moving average

13.43

Dividends and splits

Forward annual dividend rate

2.00

Forward annual dividend yield

0.23

Trailing annual dividend rate

0.50%

Trailing annual dividend yield

0.05

5-Year annual dividend yield

Payout ratio

50.00

Dividend date

April 30th, 2024

Ex-dividend date

April 26th, 2024

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

December 31th, 2023

Profitability

Profit margin

-0.38%

Operating margin

5.80%

Operational effectiveness

Return on assets

1.03%

Return on equity

-0.21%

Income statement

Revenue (ttm)

11.35

Revenue per share (ttm)

11.35

Quarterly revenue growth (yoy)

-0.29

Gross profit (ttm)

157.60M

EBITDA

69.70M

Net income to common (ttm)

-1,800,000.00

Diluted EPS (ttm)

-0.05

Quarterly earnings growth (yoy)

-28.80%

Balance sheet

Total cash (mrq)

140.70M

Total cash per share (mrq)

3.45

Total debt (mrq)

363.90M

Total Debt/Equity (mrq)

77.34

Current ratio (mrq)

147.80%

Book value per share (mrq)

11.30

Cash flow

Cash flow statement

69.30M

Levered free cash flow (LFCF)

37.14M